COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 87,819,638
Number of holders: 18
Total 13F shares, excl. options: 1,334,704
Shares change: +1,334,704
Total reported value, excl. options: $8,437,000
Value change: +$8,437,000
Number of buys: 18
Price: $6.32

Significant Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q4 2021

18 filings reported holding CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q4 2021.
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,334,704 shares of 87,819,638 outstanding shares and own 1.52% of the company stock.
Largest 10 shareholders include Prosight Management, LP (301,979 shares), Nantahala Capital Management, LLC (209,588 shares), AMERICAN FINANCIAL GROUP INC (205,000 shares), P.A.W. CAPITAL CORP (100,000 shares), Kestra Advisory Services, LLC (95,112 shares), TWO SIGMA INVESTMENTS, LP (83,398 shares), TWO SIGMA ADVISERS, LP (68,900 shares), VANGUARD GROUP INC (58,579 shares), MILLENNIUM MANAGEMENT LLC (56,419 shares), and B. Riley Financial, Inc. (30,904 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.